Integrative approach for prioritizing cancer genes in sporadic colon cancer

Genes Chromosomes and Cancer

Volumn 48, Issue 11, 2009, Pages 953-962

  Reid, James F ^a,b   Gariboldi, Manuela ^a,b   Sokolova, Viktorija ^a,b   Capobianco, Patrizia ^a,b   Lampis, Andrea ^a   Perrone, Federica ^a   Signoroni, Stefano ^a   Costa, Aurora ^a   Leo, Ermanno ^a   Pilotti, Silvana ^a   Pierotti, Marco A ^a,b  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b FIRC INSTITUTE OF MOLECULAR ONCOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; PROTEIN P53;

ADULT; AGED; ARTICLE; CHROMOSOMAL INSTABILITY; CLINICAL ARTICLE; COLON CANCER; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; GENE MUTATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; HUMAN; MALE; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; TUMOR GENE;

ADENOMATOUS POLYPOSIS COLI PROTEIN; ADULT; AGED; AGED, 80 AND OVER; ARTIFICIAL INTELLIGENCE; CHROMOSOMAL INSTABILITY; CHROMOSOMES, HUMAN, PAIR 18; COLONIC NEOPLASMS; FEMALE; GENE DOSAGE; GENE EXPRESSION PROFILING; HUMANS; LOSS OF HETEROZYGOSITY; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTO-ONCOGENE PROTEINS; RAS PROTEINS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 70349310231     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20697     Document Type: Article

References (47)

1. Arai T, Akiyama Y, Nagasaki H, Murase N, Okabe S, Ikeuchi T, Saito K, Iwai T, Yuasa Y. 1999. EXTL3/EXTR1 alterations in colorectal cancer cell lines. Int J Oncol 15:915-919.
2. Barber LJ, Youds J, Ward J, McIlwraith MJ, O'Neil NJ, I PM, Martin JS, Collis SJ, Cantor SB, Auclair M, Tissenbaum H, West S, Rose A, Boulton S. 2008. RTEL1 maintains genomic stability by suppressing homologous recombination. Cell 135:261-271.
3. Benjamini Y, Hochberg Y. 1995. Controlling the false discovery rate: A practical and powerful approach to multiple testing. J R Statist Soc B 57:289-300.
4. Carvalho B, Postma C, Mongera S, Hopmans E, Diskin S, van de Wiel MAA, van Criekinge W, Thas O, Matthäi A, Cuesta MAA, Jochim, Mikael, Schröck E, Ylstra B, Meijer GAA. 2009. Multiple putative oncogenes at the chromosome 20q amplicon contribute to colorectal adenoma to carcinoma progression. Gut 58:79-89.
5. Chen W, Hu XT, Shi QL, Zhang FB, He C. 2009. Knockdown of the novel proteasome subunit Adrm1 located on the 20q13 amplicon inhibits colorectal cancer cell migration, survival and tumorigenicity. Oncol Rep 21:531-537.
6. Diep CB, Kleivi K, Ribeiro FR, Teixeira MR, Lindgjaerde OC, Lothe RA. 2006. The order of genetic events associated with colorectal cancer progression inferred from meta-analysis of copy number changes. Genes Chromosomes Cancer 45:31-41. (Pubitemid 46930859)
7. Draviam VM, Shapiro I, Aldridge B, Sorger PK. 2006. Misorientation and reduced stretching of aligned sister kinetochores promote chromosome missegregation in EB1- or APC-depleted cells. EMBO J 25:2814-2827. (Pubitemid 43980388)
8. Duffy MJ, van Dalen A, Haglund C, Hansson L, Holinski-Feder E, Klapdor R, Lamerz R, Peltomaki P, Sturgeon C, Topolcan O. 2007. Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use. Eur J Cancer 43:1348-1360. (Pubitemid 46874070)
9. Durinck S, Moreau Y, Kasprzyk A, Davis S, De Moor B, Brazma A, Huber W. 2005. BioMart and Bioconductor: A powerful link between biological databases and microarray data analysis. Bioinformatics 21:3439-3440. (Pubitemid 41222455)
10. Fearon ER, Vogelstein B. 1990. A genetic model for colorectal tumorigenesis. Cell 61:759-767.
11. Firestein R, Bass AJ, Kim SY, Dunn IF, Silver SJ, Guney I, Freed E, Ligon AH, Vena N, Ogino S, Chheda MG, Tamayo P, Finn S, Shrestha Y, Boehm JS, Jain S, Bojarski E, Mermel C, Barretina J, Chan JA, Baselga J, Tabernero J, Root DE, Fuchs CS, Loda M, Shivdasani RA, Meyerson M, Hahn WC. 2008. CDK8 is a colorectal cancer oncogene that regulates beta-catenin activity. Nature 455:547-551.
12. Frattini M, Balestra D, Suardi S, Oggionni M, Alberici P, Radice P, Costa A, Daidone MG, Leo E, Pilotti S, Bertario L, Pierotti MA. 2004. Different genetic features associated with colon and rectal carcinogenesis. Clin Cancer Res 10:4015-4021. (Pubitemid 38812476)
13. Futreal PA, Coin L, Marshall M, Down T, Hubbard T, Wooster R, Rahman N, Stratton MR. 2004. A census of human cancer genes. Nat Rev Cancer 4:177-183.
14. Gentleman R, Carey V, Huber W, Irizarry R, Dudoit S, editors. 2005. Bioinformatics and Computational Biology Solutions Using R and Bioconductor. Statistics for Biology and Health. New-York, Springer-Verlag.
15. Grady WM, Carethers JM. 2008. Genomic and epigenetic instability in colorectal cancer pathogenesis. Gastroenterology 135:1079-1099.
16. Green RA, Wollman R, Kaplan KB. 2005. APC and EB1 function together in mitosis to regulate spindle dynamics and chromosome alignment. Mol Biol Cell 16:4609-4622. (Pubitemid 41416445)
17. Habermann JK, Paulsen U, Roblick UJ, Upender MBB, Mc Shane LMM, Korn ELL, Wangsa D, Krüger S, Duchrow M, Bruch HPP, Auer G, Ried T. 2007. Stage-specific alterations of the genome, transcriptome, and proteome during colorectal carcinogenesis. Genes Chromosomes Cancer 46:10-26. (Pubitemid 44772868)
18. Hermsen M, Postma C, Baak J, Weiss M, Rapallo A, Sciutto A, Roemen G, Arends JW, Williams R, Giaretti W, De Goeij A, Meijer G. 2002. Colorectal adenoma to carcinoma progression follows multiple pathways of chromosomal instability. Gastroenterology 123:1109-1119.
19. Higgins ME, Claremont M, Major JE, Sander C, Lash AE. 2007. CancerGenes: A gene selection resource for cancer genome projects. Nucleic Acids Res 35:D721-D726. (Pubitemid 46056298)
20. Inoue Y, Imamura T. 2008. Regulation of TGF-beta family signaling by E3 ubiquitin ligases. Cancer Sci 99:2107-2112.
21. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP. 2003. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4:249-264.
22. Joslyn G, Carlson M, Thliveris A, Albertsen H, Gelbert L, Samowitz W, Groden J, Stevens J, Spirio L, Robertson M. 1991. Identification of deletion mutations and three new genes at the familial polyposis locus. Cell 66:601-613. (Pubitemid 121001395)
23. Kawasaki Y, Sagara M, Shibata Y, Shirouzu M, Yokoyama S, Akiyama T. 2007. Identification and characterization of Asef2, a guanine-nucleotide exchange factor specific for Rac1 and Cdc42. Oncogene 26:7620-17267 (Pubitemid 350224217)
24. Kim JE, Chen J, Lou Z. 2008. DBC1 is a negative regulator of SIRT1. Nature 451:583-586.
25. Klijn C, Holstege H, de Ridder J, Liu X, Reinders M, Jonkers J, Wessels L. 2008. Identification of cancer genes using a statistical framework for multiexperiment analysis of nondiscretized array CGH data. Nucleic Acids Res 36:e13. (Pubitemid 351250463)
26. Leisch F. 2002. Sweave: Dynamic generation of statistical reports using literate data analysis. In: Härdle W, Rönz B, editors. Compstat 2002 - Proceedings in Computational Statistics. Heidelberg: Physica Verlag, pp. 575-580.
27. Locker GY, Hamilton S, Harris J, Jessup JM, Kemeny N, Macdonald JS, Somerfield MR, Hayes DF, Bast RC, Jr. 2006. ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol 24:5313-5327.
28. Macartney-Coxson DP, Hood KA, Shi HJ, Ward T, Wiles A, O'Connor R, Hall DA, Lea RA, Royds JA, Stubbs RS, Rooker S. 2008. Metastatic susceptibility locus, an 8p hot-spot for tumour progression disrupted in colorectal liver metastases: 13 candidate genes examined at the DNA, mRNA and protein level. BMC Cancer 8:187.
29. Manenti G, Trincucci G, Pettinicchio A, Amendola E, Scarfò M, Dragani TA. 2008. Cis-acting genomic elements of the Pas1 locus control Kras mutability in lung tumors. Oncogene 27:5753-5758.
30. R Development Core Team. 2008. R: A Language and Environment for Statistical Computing. Vienna, Austria: R Foundation for Statistical Computing.
31. Ramalingam A, Duhadaway JB, Sutanto-Ward E, Wang Y, Dinchuk J, Huang M, Donover PS, Boulden J, McNally LM, Soler AP, Muller AJ, Duncan MK, Prendergast GC. 2008. Bin3 deletion causes cataracts and increased susceptibility to lymphoma during aging. Cancer Res 68:1683-1690.
32. Rodilla V, Villanueva A, Obrador-Hevia A, Robert-Moreno A, Fernández-Majada V, Grilli A, López-Bigas N, Bellora N, Albà MM, Torres F, Duñach M, Sanjuan X, Gonzalez S, Gridley T, Capella G, Bigas A, Espinosa L. 2009. Jagged1 is the pathological link between Wnt and Notch pathways in colorectal cancer. Proc Natl Acad Sci USA 106:6315-6320.
33. Sala G, Dituri F, Raimondi C, Previdi S, Maffucci T, Mazzoletti M, Rossi C, Iezzi M, Lattanzio R, Piantelli M, Iacobelli S, Broggini M, Falasca M. 2008. Phospholipase Cgamma1 is required for metastasis development and progression. Cancer Res 68:10187-10196.
34. Samowitz WS, Slattery ML, Sweeney C, Herrick J, Wolff RK, Albertsen H. 2007. APC mutations and other genetic and epigenetic changes in colon cancer. Mol Cancer Res 5:165-170. (Pubitemid 46423997)
35. Sawabu T, Seno H, Kawashima T, Fukuda A, Uenoyama Y, Kawada M, Kanda N, Sekikawa A, Fukui H, Yanagita M, Yoshibayashi H, Satoh S, Sakai Y, Nakano T, Chiba T. 2007. Growth arrest-specific gene 6 and Axl signaling enhances gastric cancer cell survival via Akt pathway. Mol Carcinog 46:155-164. (Pubitemid 46272123)
36. Shih IM, Zhou W, Goodman SN, Lengauer C, Kinzler KW, Vogelstein B. 2001. Evidence that genetic instability occurs at an early stage of colorectal tumorigenesis. Cancer Res 61:818-822. (Pubitemid 32174384)
37. Sjöblom T, Jones S, Wood LD, Parsons WD, Lin J, Barber T, Mandelker D, Leary RJ, Ptak J, Silliman N, Szabo S, Buckhaults P, Farrell C, Meeh P, Markowitz SD, Willis J, Dawson D, Willson JK, Gazdar AF, Hartigan J, Wu L, Liu C, Parmigiani G, Park BH, Bachman KE, Papadopoulos N, Vogelstein B, Kinzler KW, Velculescu VE. 2006. The consensus coding sequences of human breast and colorectal cancers. Science 314:268-274. (Pubitemid 44571966)
38. Smith G, Carey FA, Beattie J, Wilkie MJ, Lightfoot TJ, Coxhead J, Garner CR, Steele RJ, Wolf RC. 2002. Mutations in APC, Kirsten-ras, and p53-alternative genetic pathways to colorectal cancer. Proc Natl Acad Sci USA 99:9433-9438. (Pubitemid 34764631)
39. Song K, Wang H, Krebs TL, Danielpour D. 2006. Novel roles of Akt and mTOR in suppressing TGF-beta/ALK5-mediated Smad3 activation. EMBO J 25:58-69. (Pubitemid 43077295)
40. Staub E, Groene J, Mennerich D, Roepcke S, Klaman I, Hinzmann B, Castanos-Velez E, Mann B, Pilarsky C, Brummendorf T, Weber B, Buhr HJ, Rosenthal A. 2006. A genome-wide map of aberrantly expressed chromosomal islands in colorectal cancer. Mol Cancer 5:37. (Pubitemid 44574976)
41. Takahashi Y, Ishii Y, Nishida Y, Ikarashi M, Nagata T, Nakamura T, Yamamori S, Asai S. 2006. Detection of aberrations of ubiquitin-conjugating enzyme E2C gene (UBE2C) in advanced colon cancer with liver metastases by DNA microarray and two-color FISH. Cancer Genet Cytogenet 168:30-35. (Pubitemid 44183675)
42. Tsafrir D, Bacolod M, Selvanayagam Z, Tsafrir I, Shia J, Zeng Z, Liu H, Krier C, Stengel RF, Barany F, Gerald WL, Paty PB, Domany E, Notterman DA. 2006. Relationship of gene expression and chromosomal abnormalities in colorectal cancer. Cancer Res 66:2129-2137. (Pubitemid 43294922)
43. Wang Z, Wang F, Wang WQ, Gao Q, Wei WL, Yang Y, Wang GY. 2004. Correlation of N-myc downstream-regulated gene 1 overexpression with progressive growth of colorectal neoplasm. World J Gastroenterol 10:550-554. (Pubitemid 38325313)
44. Wood LD, Parsons DW, Jones S, Lin J, Sjöblom T, Leary RJJ, Shen D, Boca SMM, Barber T, Ptak J, Silliman N, Szabo S, Dezso Z, Ustyanksky V, Nikolskaya T, Nikolsky Y, Karchin R, Wilson PAA, Kaminker JSS, Zhang Z, Croshaw R, Willis J, Dawson D, Shipitsin M, Willson JKVK, Sukumar S, Polyak K, Park BHH, Pethiyagoda CLL, Pant PVKV, Ballinger DGG, Sparks ABB, Hartigan J, Smith DRR, Suh E, Papadopoulos N, Buckhaults P, Markowitz SDD, Parmigiani G, Kinzler KWW, Velculescu VEE, Vogelstein B. 2007. The genomic landscapes of human breast and colorectal cancers. Science 318:1108-1113. (Pubitemid 350134889)
45. Wu S, Shi Y, Mulligan P, Gay F, Landry J, Liu H, Lu J, Qi HH, Wang W, Nickoloff JA, Wu C, Shi Y. 2007. A YY1-INO80 complex regulates genomic stability through homologous recombination-based repair. Nat Struct Mol Biol 14:1165-1172. (Pubitemid 350223334)
46. Yasui K, Arii S, Zhao C, Imoto I, Ueda M, Nagai H, Emi M, Inazawa J. 2002. TFDP1, CUL4A, and CDC16 identified as targets for amplification at 13q34 in hepatocellular carcinomas. Hepatology 35:1476-1484. (Pubitemid 34966902)
47. Zhao W, Kruse JP, Tang Y, Jung SY, Qin J, Gu W. 2008. Negative regulation of the deacetylase SIRT1 by DBC1. Nature 451:587-590. (Pubitemid 351186268)